Rovalpituzumab Biosimilar – Anti-DLL3 mAb – Research Grade

Reference:
Product nameRovalpituzumab Biosimilar - Anti-DLL3 mAb - Research Grade
SourceCAS 1613313-01-1
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsRovalpituzumab,,DLL3,anti-DLL3
ReferencePX-TA1397
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Rovalpituzumab Biosimilar - Anti-DLL3 mAb - Research Grade

General information on Anti-DLL3[Homo sapiens] (Rovalpituzumab) Monoclonal Antibody

Rovalpituzumab has been investigated for the treatment of Glioblastoma, Malignant Melanoma, Other Solid Tumors, Small Cell Lung Cancer, and Medullary Thyroid Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Rovalpituzumab Biosimilar – Anti-DLL3 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 214$
Stable Isotope Labelled Rovalpituzumab Biosimilar – Anti-DLL3 mAb – Research Grade
SIL

Stable Isotope Labelled Rovalpituzumab Biosimilar – Anti-DLL3 mAb – Research Grade

PX-TA1397-SIL 17850$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products